Literature DB >> 29409763

Knockout of the CCCH zinc finger protein TcZC3H31 blocks Trypanosoma cruzi differentiation into the infective metacyclic form.

Monica Visnieski Alcantara1, Rafael Luis Kessler1, Rosana Elisa Gonçalves Gonçalves1, Newmar Pinto Marliére2, Alessandra Aparecida Guarneri2, Gisele Fernanda Assine Picchi1, Stenio Perdigão Fragoso3.   

Abstract

In the protozoan parasite Trypanosoma cruzi - the causative agent of Chagas disease - gene expression control is mainly post-transcriptional, where RNA-binding proteins (RBPs) play a central role, by controlling mRNA stability, distribution and translation. A large variety of RBPs are encoded in the T. cruzi genome, including the CCCH-type zinc finger (CCCH ZnF) protein family, which is characterized by the presence of the C-X7/8-C-X5-C-X3-H (CCCH) motif. In the related parasite T. brucei, CCCH ZnF proteins have been shown to control key differentiation steps in the parasite's life cycle. However, little is known about the CCCH ZnF proteins in T. cruzi. We have worked on the generation of T. cruzi mutants for CCCH ZnF proteins in an effort to shed light on the functions of these proteins in this parasite. Here, we characterize the expression and function of the CCCH ZnF protein TcZC3H31 of T. cruzi. TcZC3H31 is almost exclusively expressed in epimastigotes and metacyclic trypomastigotes, the parasite forms found in the invertebrate host. Importantly, we show that the epimastigote form of the T. cruzi knockout for the TcZC3H31 gene (TcZC3H31 KO) is incapable, both in vitro and in vivo (in infected triatomine insects), to differentiate into the metacyclic trypomastigote form, which is responsible for infection transmission from vectors to humans. The epimastigote forms recovered from the excreta of insects infected with TcZC3H31 KO parasites do not have the typical epimastigote morphology, suggesting that parasites are arrested in a mid-differentiation step. Also, epimastigotes overexpressing TcZC3H31 differentiate into metacyclics more efficiently than wild-type epimastigotes, in vitro. These data suggest that TcZC3H31 is an essential positive regulator of T. cruzi differentiation into the human-infective metacyclic form.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCCH zinc finger protein; Metacyclogenesis; RNA binding protein; Trypanosoma cruzi

Mesh:

Substances:

Year:  2018        PMID: 29409763     DOI: 10.1016/j.molbiopara.2018.01.006

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  The RNA-binding protein TcUBP1 up-regulates an RNA regulon for a cell surface-associated Trypanosoma cruzi glycoprotein and promotes parasite infectivity.

Authors:  Karina B Sabalette; María Albertina Romaniuk; Griselda Noé; Alejandro Cassola; Vanina A Campo; Javier G De Gaudenzi
Journal:  J Biol Chem       Date:  2019-05-21       Impact factor: 5.157

2.  Metacyclogenesis defects and gene expression hallmarks of histone deacetylase 4-deficient Trypanosoma cruzi cells.

Authors:  Gisele Fernanda Assine Picchi-Constante; Eloise Pavão Guerra-Slompo; Ana Carolina Tahira; Monica Visnieski Alcantara; Murilo Sena Amaral; Arthur Schveitzer Ferreira; Michel Batista; Cassiano Martin Batista; Samuel Goldenberg; Sergio Verjovski-Almeida; Nilson Ivo Tonin Zanchin
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

3.  RNA Binding Proteins and Gene Expression Regulation in Trypanosoma cruzi.

Authors:  Bruno A A Romagnoli; Fabiola B Holetz; Lysangela R Alves; Samuel Goldenberg
Journal:  Front Cell Infect Microbiol       Date:  2020-02-20       Impact factor: 5.293

4.  A Trypanosoma cruzi zinc finger protein that is implicated in the control of epimastigote-specific gene expression and metacyclogenesis.

Authors:  Thais S Tavares; Fernanda L B Mügge; Viviane Grazielle-Silva; Bruna M Valente; Wanessa M Goes; Antonio E R Oliveira; Ashton T Belew; Alessandra A Guarneri; Fabiano S Pais; Najib M El-Sayed; Santuza M R Teixeira
Journal:  Parasitology       Date:  2020-11-16       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.